| Sign In to gain access to subscriptions and/or personal tools. |
Ganoderma Lucidum(Reishi) in Cancer TreatmentCancer Research Laboratory, Methodist Research Institute, 1800 N Capitol Ave, E504, Indianapolis, IN 46202.d-silva{at}clarian.org The popular edible mushroom Ganoderma lucidum(Reishi) has been widely used for the general promotion of health and longevity in Asian countries. The dried powder of Ganoderma lucidumwas popular as a cancer chemotherapy agent in ancient China. The authors recently demonstrated thatGanoderma luciduminhibits constitutively active transcription factors nuclear factor kappa B (NF-.B) and AP-1, which resulted in the inhibition of expression of urokinasetype plasminogen activator (uPA) and its receptor uPAR.Ganoderma lucidumalso suppressed cell adhesion and cell migration of highly invasive breast and prostate cancer cells, suggesting its potency to reduce tumor invasiveness. Thus, Ganoderma lucidumclearly demonstrates anticancer activity in experiments with cancer cells and has possible therapeutic potential as a dietary supplement for an alternative therapy for breast and prostate cancer. However, because of the availability of Ganoderma lucidum from different sources, it is advisable to test its biologic activity.
Key Words: Ganoderma lucidum Reishi breast and prostate cancer signaling pathways AP-1 NF- B uPA uPAR
Integrative Cancer Therapies, Vol. 2, No. 4,
358-364 (2003) This article has been cited by other articles:
| ||||||||||||||
